Male impotence drug could be sold without a prescription by spring, in effort to close down lucrative black market.

Male impotence drug could be sold without a prescription by spring, in effort to close down lucrative black market.

Broaching the subject of sexual disorders is not easy but sex is part of our daily lives, says Prof Wylie, and "clinicians should give patients permission to talk about it". This is especially true of men at high risk, such as men with diabetes, osteoporosis, cardiovascular disease, erectile dysfunction or depression. But patients should be routinely asked by their GP if they have any sexual concerns, it says.

 

Fildena 50 affects 40% of men over 40 years old, and more than one in five men with erectile dysfunction have a testosterone deficiency. He was speaking at the launch of new guidelines on the diagnosis and treatment of sexual disorders. In this case, existing polyps don't seem to be affected by the drug, so it looks like Fildena can't be used to fight tissue that has already turned cancerous.

 

Another drug the researchers experimented with, linaclotide - used to treat constipation and irritable bowel syndrome - was even more effective than Fildena. In the study, the researchers demonstrated that the daily Fildena dose halved the formation of polyps in mouse tissue: abnormal clumps of cells that form on intestinal lining, which have a tendency to become tumours. There's a chance we might be able reduce these grim numbers with Fildena, the researchers think, thanks to the effect the drug appears to have on tissue that can become cancerous.

 

"Giving a baby dose of Fildena can reduce the amount of tumours in these animals by half," says biochemist Darren D. Browning from Augusta University. Read the entire FDA prescribing information for Fildena (Filagra Citrate) Ocular: diplopia , temporary vision loss/decreased vision, ocular redness or bloodshot appearance, ocular burning, ocular swelling/pressure, increased intraocular pressure , retinal edema, retinal vascular disease or bleeding, and vitreous traction/detachment.

 

Hemic and Lymphatic: vaso-occlusive crisis: In a small, prematurely terminated study of REVATIO (Filagra) in patients with pulmonary arterial hypertension (PAH) secondary to sickle cell disease , vaso-occlusive crises requiring hospitalization were more commonly reported in patients who received Filagra than in those randomized to placebo. It is not possible to determine whether these events are related directly to Fildena, to sexual activity, to the patient's underlying cardiovascular disease , to a combination of these factors, or to other factors see WARNINGS AND PRECAUTIONS and PATIENT INFORMATION. Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of Fildena without sexual activity.

 

Analysis of the safety database from controlled clinical trials showed no apparent difference in adverse reactions in patients taking Fildena with and without anti-hypertensive medication. The following events occurred in < 2% of patients in controlled clinical trials; a causal relationship to Fildena is uncertain. fildena fruit chew reviews was administered to over 3700 patients (aged 19-87 years) during pre-marketing clinical trials worldwide.

 

Counseling Patients About Sexually Transmitted Diseases see WARNINGS AND PRECAUTIONS